ITPKB is a conserved regulator of natural killer cell desensitization/education that constrains antitumor immunity

Yeara Jo1, Alexandros Karampatzakis1, Seung Won Lee1

  • 1Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.

Insights

Persistent stimulation causes Natural Killer (NK) cell desensitization, hindering antitumor immunity. Inhibiting Inositol trisphosphate kinase B (ITPKB) restores NK cell function and enhances tumor control, offering a new therapeutic strategy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Mechanisms

Background:

  • Persistent stimulation leads to Natural Killer (NK) cell desensitization, compromising durable antitumor immunity.
  • The molecular underpinnings of NK cell dysfunction during chronic activation are not well understood.
  • Identifying regulators of NK cell desensitization is crucial for improving cancer immunotherapy.

Purpose of the Study:

  • To identify conserved molecular regulators of NK cell desensitization.
  • To investigate the role of Inositol trisphosphate kinase B (ITPKB) in NK cell dysfunction.
  • To evaluate the therapeutic potential of targeting ITPKB for enhancing NK cell-mediated antitumor immunity.

Main Methods:

  • Comparative transcriptomic analyses in murine models of persistent NK cell activation.
  • Genetic and pharmacological inhibition of ITPKB in murine and human NK cells.
  • Assessment of NK cell functions including degranulation, cytokine production, and cytotoxicity.
  • Investigation of signaling pathways involving IP3/IP4 axis and calcium mobilization.
  • Evaluation of NK cell-mediated tumor control in vivo and CAR-NK cell efficacy.

Main Results:

  • Transcriptomic analysis identified a shared program of NK cell desensitization, with upregulation of ITPKB.
  • Inhibition of ITPKB restored degranulation, cytokine production, and cytotoxicity in desensitized NK cells.
  • ITPKB regulates NK cell signaling via the IP3/IP4 axis, impacting calcium mobilization and NFAT activity.
  • ITPKB inhibition enhanced NK cell-mediated tumor control in vivo and improved CAR-NK cell therapy efficacy.

Conclusions:

  • ITPKB is a key cell-intrinsic regulator of NK cell desensitization.
  • Targeting ITPKB can overcome NK cell dysfunction induced by persistent stimulation.
  • Modulating the IP3/IP4 signaling axis represents a promising strategy to enhance NK cell-based cancer immunotherapy.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...